Načítá se...
Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence
INTRODUCTION: Despite being frequently diagnosed, there has been very limited study of efficacious treatments for schizoaffective disorder. Paliperidone had been approved for the treatment of schizoaffective disorder, and a recently completed relapse prevention study of the use of a once-monthly inj...
Uloženo v:
| Vydáno v: | Neurol Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4685865/ https://ncbi.nlm.nih.gov/pubmed/26662360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-015-0030-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|